Simple Summary The application of non-steroidal anti-inflammatory drugs (NSAIDs) in
cancer therapy has been a widely studied topic for almost four decades. This review …

Pyroptosis, an emerging mechanism of programmed cell death, holds great potential to
trigger a robust antitumor immune response. Platinum‐based chemotherapeutic agents can …

Despite significant treatment efforts, pancreatic ductal adenocarcinoma (PDAC), the
deadliest solid tumor, is still incurable in the preclinical stages due to multifacet stroma …

Carcinoma-associated pancreatic fibroblasts (CAFs) are the major type of cells in the stroma
of pancreatic ductal adenocarcinomas and besides their pathological release of …

Current asthma therapies focus on reducing symptoms but fail to restore existing structural
damage. Mesenchymal stromal cell (MSC) administration can ameliorate airway …

The anti-breast cancer stem cell (CSC) properties of a series of gold (I) complexes
comprising various non-steroidal anti-inflammatory drugs (NSAIDs) and triphenylphosphine …

Hypoxic microenvironment and pancreatic stellate cells (PSCs) play important roles in
pancreatic cancer progression. PSCs secrete a number of soluble factors, such as …

Photodynamic therapy, during which nontoxic photosensitizers can be photo-activated to
generate cytotoxic reactive oxygen species, has attracted great interest. However, the strong …

Inflammation is a key contributor to both the initiation and progression of tumors, and it can
be triggered by genetic instability within tumors, as well as by lifestyle and dietary factors …

Inflammation plays a pivotal role in various pathological processes, ranging from routine
injuries and infections to cancer. Cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) …